<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-title><trans-title-group xml:lang="ru"><trans-title>Физиотерапия, бальнеология и реабилитация</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1681-3456</issn><issn publication-format="electronic">2413-2969</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">702042</article-id><article-id pub-id-type="doi">10.17816/rjpbr702042</article-id><article-id pub-id-type="edn">CPJMJH</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Review</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Ozone therapy in ophthalmology</article-title><trans-title-group xml:lang="ru"><trans-title>Озонотерапия в офтальмологии</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>臭氧疗法在眼科学中的应用</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1408-3308</contrib-id><contrib-id contrib-id-type="spin">3555-8772</contrib-id><name-alternatives><name xml:lang="en"><surname>Kulikov</surname><given-names>Aleksander G.</given-names></name><name xml:lang="ru"><surname>Куликов</surname><given-names>Александр Геннадьевич</given-names></name><name xml:lang="zh"><surname>Kulikov</surname><given-names>Aleksander G.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><email>ag-kulikov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-8032-0777</contrib-id><contrib-id contrib-id-type="spin">1840-4070</contrib-id><name-alternatives><name xml:lang="en"><surname>Velikanova</surname><given-names>Tatiana N.</given-names></name><name xml:lang="ru"><surname>Великанова</surname><given-names>Татьяна Николаевна</given-names></name><name xml:lang="zh"><surname>Velikanova</surname><given-names>Tatiana N.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>tnw09@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8374-2645</contrib-id><contrib-id contrib-id-type="spin">8648-6881</contrib-id><name-alternatives><name xml:lang="en"><surname>Kheilo</surname><given-names>Tatiana S.</given-names></name><name xml:lang="ru"><surname>Хейло</surname><given-names>Татьяна Сергеевна</given-names></name><name xml:lang="zh"><surname>Kheilo</surname><given-names>Tatiana S.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>cto96@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Burnasyan Federal Medical Biophysical Center</institution></aff><aff><institution xml:lang="ru">Федеральный медицинский биофизический центр им. А.И. Бурназяна</institution></aff><aff><institution xml:lang="zh">Burnasyan Federal Medical Biophysical Center</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Krasnov Research Institute Of Eye Diseases</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт глазных болезней им. М.М. Краснова</institution></aff><aff><institution xml:lang="zh">Krasnov Research Institute Of Eye Diseases</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Center of Therapeutic Ophthalmology</institution></aff><aff><institution xml:lang="ru">Центр терапевтической офтальмологии</institution></aff><aff><institution xml:lang="zh">Center of Therapeutic Ophthalmology</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-02-17" publication-format="electronic"><day>17</day><month>02</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-04-19" publication-format="electronic"><day>19</day><month>04</month><year>2026</year></pub-date><volume>25</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>127</fpage><lpage>137</lpage><history><date date-type="received" iso-8601-date="2026-02-01"><day>01</day><month>02</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-02-12"><day>12</day><month>02</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><copyright-holder xml:lang="zh">Eco-Vector</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://eco-vector.com/for_authors.php#07</ali:license_ref></license></permissions><self-uri xlink:href="https://rjpbr.com/1681-3456/article/view/702042">https://rjpbr.com/1681-3456/article/view/702042</self-uri><abstract xml:lang="en"><p>This review presents an analysis of Russian and international publications on the use of ozone in ophthalmologic diseases, highlighting its pronounced antibacterial and antiviral effects, ability to suppress inflammation, improve local hemodynamics and microcirculation, and normalize impaired blood rheological parameters. A beneficial effect of ozone on metabolic and reparative processes has been established. Course administration of this method was shown to reduce lipid peroxidation activity while simultaneously stimulating the antioxidant system. A positive effect of local ozone therapy techniques has been demonstrated in intraocular infections. Experimental and clinical studies have elucidated the mechanisms of the therapeutic action of ozone in fungal and viral keratitis and in patients with ischemia–reperfusion retinal injury. Ozone has been shown to be an effective therapeutic modality for neurodegenerative disorders at early stages of age-related changes before progression to severe pathology. Ozone therapy for uveitis of various etiologies reduces the time to resolution of choroidal infiltration and the overall duration of treatment. The beneficial role of ozone therapy has been confirmed in high myopia and glaucoma, as well as its successful application in hemophthalmos, particularly in the early period after hemorrhage. Favorable clinical outcomes have been reported with both local and systemic ozone therapy techniques in patients with diabetic retinopathy. The multifactorial mechanisms underlying the therapeutic and preventive effects of ozone, ease of administration, good tolerability, and availability of modern equipment allow for the broad use of this method in ophthalmologic practice.</p></abstract><trans-abstract xml:lang="ru"><p>В обзоре представлен анализ российских и зарубежных публикаций по применению озона при офтальмологических заболеваниях, в которых отмечена его способность оказывать выраженное антибактериальное и противовирусное действие, купировать воспалительный процесс, улучшать локальную гемодинамику и процессы микрогемоциркуляции, устранять нарушенные реологические показатели крови. Установлено благоприятное влияние озона на метаболические и репаративные процессы. Курсовое применение данного метода позволяло снижать активность перекисного окисления липидов на фоне стимуляции антиоксидантной системы. Доказан положительный эффект локальных методик озонотерапии при внутриглазной инфекции. Экспериментальными и клиническими исследованиями раскрыты механизмы лечебного действия озона при кератитах грибкового и вирусного происхождения, у пациентов с ишемически-реперфузионными повреждениями сетчатки. Установлена роль озона в качестве эффективного метода борьбы с нейродегенеративными заболеваниями на ранней стадии возрастных изменений до развития тяжёлой патологии. Озонотерапия увеитов различной этиологии позволяет сокращать сроки резорбции инфильтрации сосудистой оболочки и длительность лечения. Подтверждена положительная роль озонотерапии при наличии миопии высокой степени и глаукомы, возможность её успешного применения при гемофтальме, особенно в ранние сроки после кровоизлияния. Хорошие клинические результаты были выявлены при использовании локальных и системных методик озонотерапии у пациентов с диабетической ретинопатией. Многовекторность механизмов лечебного и профилактического действия озона, простота выполнения и хорошая переносимость лечебных методик, наличие современной аппаратуры позволяют широко использовать данный метод в офтальмологической практике.</p></trans-abstract><trans-abstract xml:lang="zh"><p>本综述分析了俄罗斯及国外关于臭氧在眼科疾病中应用的文献，指出其具有显著的抗菌和抗病毒作用，能够抑制炎症过程，改善局部血流动力学和微循环，纠正异常的血液流变学指标。已证实臭氧对代谢和修复过程具有积极影响。该疗法的系统性应用可在激活抗氧化系统的同时，降低脂质过氧化活性。局部臭氧疗法在眼内感染中的积极作用已得到证实。实验和临床研究揭示了臭氧在真菌性及病毒性角膜炎、视网膜缺血-再灌注损伤患者中的治疗作用机制。证实了臭氧在年龄相关性改变的早期阶段、在严重病理发展之前，作为对抗神经退行性疾病的有效方法的作用。 对于不同病因的葡萄膜炎，臭氧疗法可缩短脉络膜浸润的吸收时间及整体治疗周期。臭氧疗法在高度近视和青光眼中的积极作用已得到确认，其在玻璃体积血（尤其是出血早期）中的应用亦显示出良好前景。在糖尿病视网膜病变患者中，局部及全身应用臭氧疗法均取得了良好的临床效果。臭氧疗法作用机制的多维性、操作简便、耐受性良好以及现代化设备的普及，使得该方法在眼科临床实践中得以广泛应用。</p></trans-abstract><kwd-group xml:lang="en"><kwd>ozone therapy</kwd><kwd>ophthalmology</kwd><kwd>intraocular infection</kwd><kwd>keratitis</kwd><kwd>uveitis</kwd><kwd>age-related macular degeneration</kwd><kwd>diabetic retinopathy</kwd><kwd>hemophthalmos</kwd><kwd>rhegmatogenous retinal detachment</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>озонотерапия</kwd><kwd>офтальмология</kwd><kwd>внутриглазная инфекция</kwd><kwd>кератит</kwd><kwd>увеит</kwd><kwd>возрастная макулярная дегенерация</kwd><kwd>диабетическая ретинопатия</kwd><kwd>гемофтальм</kwd><kwd>регматогенная отслойка сетчатки</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>臭氧疗法</kwd><kwd>眼科学</kwd><kwd>眼内感染</kwd><kwd>角膜炎</kwd><kwd>葡萄膜炎</kwd><kwd>年龄相关性黄斑变性</kwd><kwd>糖尿病视网膜病变</kwd><kwd>玻璃体积血</kwd><kwd>孔源性视网膜脱离</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Alekhina SP, Shcherbatyuk TG. Ozone Therapy: Clinical and Experimental Aspects. Nizhny Novgorod: Litera; 2003. 240 p. (In Russ.)</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Bocci V. The case for oxygen-ozonetherapy. Br J Biomed Sci. 2007;64(1):44–9. doi: 10.1080/09674845.2007.11732755</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Isxakova RR, Sajfullina FR. Ozone therapy in ophthalmology. Kazan medical journal. 2013;94(4):510–516. EDN: QZIOJH</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Scassellati C, Galoforo AC, Bonvicini C, et al. Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders. Ageing research reviews. 2020;63:101138. doi: 10.1016/j.arr.2020.101138</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kulikov AG. Ozonotherapy: microhemodynamical aspects. Russian journal of the physical therapy, balneotherapy and rehabilitation. 2012;(3):3–8. EDN: PGPCGF</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Borrelli E, Bocci V. Visual improvement following ozonetherapy in dry age related macular degeneration: a review. Med Hypothesis Discov Innov Ophthalmol. 2013;2(2):47–51.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Maslennikov OV, Kontorshchikova KN, Shakhov BE. Manual on Ozone Therapy. 4th ed. Nizhny Novgorod: Istock; 2015. (In Russ.) EDN: WLIOQN</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gulieva MG. The effectiveness of ozone therapy in the treatment of herpetic uveitis. Russian ophthalmological journal. 2017;10(2):23–27. doi: 10.21516/2072-0076-2017-10-2-23-27 EDN: YPIZPR</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Egorov AV, Egorov VV, Smolyakova GP, Xudyakov AYu. Analysis of modern possibilities for increasing visual functions after endovitreal surgery of regmatogenous retinal detachment (literature review). Modern technologies in ophthalmology. 2020;(2):97–102. doi: 10.25276/2312-4911-2020-1-97-102 EDN: RCSJHO</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37(4):425–35. doi: 10.1016/j.arcmed.2005.08.006</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Re L, Mawsouf MN, Menéndez S, et al. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res. 2008;39(1):17–26. doi: 10.1016/j.arcmed.2007.07.005</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Marchegiani A, Spaterna A. Ozone-based eye drops in anterior segment pathologies: rationale and pre-clinical data. Ozone Therapy. 2017;2(1). doi: 10.4081/ozone.2017.6743</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Schulz S, Häussler U, Mandic R, et al. Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int J Cancer. 2008;122(10):2360–7. doi: 10.1002/ijc.23382</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Borzenok SA, Moroz ZI, Zmyzgova AV. Ozone Therapy in Ophthalmology. A Guide for Doctors. Moscow: State Institution “Microsurgery of the Eye”; 2000. 36 p. (In Russ.)</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Copello M, Menéndez S, Hernández F. Ozone Therapy in Retinitis Pigmentosa Patients: Clinical Evolution and Oxidative Stress Behavior in Retinitis Pigmentosa Patients Treated with Ozone Therapy over 20 Years. Ozone: Science &amp; Engineering. 2012;34(6):476–483. doi: 10.1080/01919512.2012.719380</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Tumanova AL. Sanatorium resort prevention and rehabilitation of eye disorders. Kurortnaya medicina. 2017;(4):114–117. EDN: XQYGNF</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Gundorova RA, Khoroshilova-Maslova IP, Bordyugova GG, Ilatovskaya LV. Experimental substantiation of the expediency of using ozonated physiological solutions in case of intraocular infection. Russian annals of ophthalmology. 1996;112(5):9–11. (In Russ.) EDN: SJWZEV</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Lapina IM, Sinelshchikova IV. Ozone therapy in ophthalmology. Bulletin of Ophthalmology. 1998;114(6):51–54. (In Russ.)</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Boyarinov GA, Boyarinova LV, Gordetsov AS, et al. Is it possible to treat biofilm bacterial infections with ozone? Biоradicals and antioxidants. 2018;5(3):162–173. (In Russ.) EDN: YLAKRN</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Yusupov AA, Yusupova MA, Yusupova NA. Increasing the effectiveness of combined treatment of viral conjunctivitis using ozone gas through glasses. Modern technologies in ophthalmology. 2018;(1):434-436. (In Russ.) EDN: YSLSVK</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Yuzhakov AM, Bykov VP, Zurnyaeva ID, Gogodze MD. New Perspectives in the Treatment of Intraocular Infection. Russian annals of ophthalmology. 2000;116(2):20–23. (In Russ.) EDN: QBTWPL</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Passidomo F, Pignatelli F, Addabbo G, Costagliola C. Topical Liposomal Ozonated Oil in Complicated Corneal Disease: A Report on Three Clinical Cases. Int Med Case Rep J. 2021;14:327–332. doi: 10.2147/IMCRJ.S311839</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Giralt IM, de Los Bueis AB, Ucero AM, Colomo PV. Management of neurotrophic corneal ulcer with a topical liposomal ozonated oil: A report on three clinical cases. Am J Ophthalmol Case Rep. 2025;38:102344. doi: 10.1016/j.ajoc.2025.102344</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Spadea L, Tonti E, Spaterna A, Marchegiani A. Use of Ozone-Based Eye Drops: A Series of Cases in Veterinary and Human Spontaneous Ocular Pathologies. Case Rep Ophthalmol. 2018;9(2):287–298. doi: 10.1159/000488846</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Pérez-Santonja JJ, Güell JL, Gris O, et.al. Liposomal Ozonated Oil in Ocular Infections: A Review of Preclinical and Clinical Studies, Focusing on Its Antiseptic and Regenerative Properties. Clin Ophthalmol. 2022;16:1953–1962. doi: 10.2147/OPTH.S360929</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Benítez-Del-Castillo JM. Liposomal ozonated oil effectiveness in the signs and symptoms of blepharitis in usual clinical practice. Eur J Ophthalmol. 2024;34(3):678–682. doi: 10.1177/11206721231207116</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Varol K, Koç AN, Çakır Bayram L, et al. Studies on the Effectiveness of Ozone Therapy on the Treatment of Experimentally Induced Keratitis with Candida albicans in Rabbits. Semin Ophthalmol. 2022;37(2):253–264. doi: 10.1080/08820538.2021.1995006</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Bystrov AM, Davydova EV, Kuznetzov AA, Sumina MS. Use of ozone therapy in the treatment of complications following penetrating keratoplasty for rosacea-associated keratitis. Russian annals of ophthalmology. 2025;141(4):66–72. doi: 10.17116/oftalma202514104166 EDN: PEVNBZ</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Sabirova DB, Yusupov AA, Iskandarov ShX, et al. Clinical evaluation of ozonotherapy and cryopeksia of patients with herpetic keratitis. Point of view. East — West. 2016;(1):147–149. EDN: WHCODL</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Bistrov AM, Davidova YV, Kuznetsov AA. The use of ozone therapy in the complex treatment of corneal transplant rejection reaction. International research journal. 2024;(10):1–6. doi: 10.60797/IRJ.2024.148.22 EDN: HMFBYI</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Osborne NN, Casson RJ, Wood JP, et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23(1):91–147. doi: 10.1016/j.preteyeres.2003.12.001</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Kal A, Kal O, Akillioglu I, et al. The protective effect of prophylactic ozone administration against retinal ischemia-reperfusion injury. Cutaneous and ocular toxicology. 2017;36(1):39–47. doi: 10.3109/15569527.2016.1156120</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Gong L, Pasquale LR, Wiggs JL, et.al. Description of a Nonhuman Primate Model of Retinal Ischemia/Reperfusion Injury. Transl Vis Sci Technol. 2023;12(6):14. doi: 10.1167/tvst.12.6.14</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Yıldız A, Şehitoğlu MH, Karaboğa İ, Arıkan S. Ozone treatment for high-dose systemic Steroid-Induced retinal injury. Cutaneous and ocular toxicology. 2020;39(3):274–280. doi: 10.1080/15569527.2020.1790590</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Kashiwagi K, Saito K, Wang YD, Takahashi H, Ishijima K, Tsukahara S. Safety of ozonated solution as an antiseptic of the ocular surface prior to ophthalmic surgery. Ophthalmologica. 2001;215(5):351–356. doi: 10.1159/000050884</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Neroev VV, Zueva MV, Tsapenko IV, Khandzhian AT. The impact made by ozone-therapy on the functional activity of the retina in patients with involutional central chorioretinal dystrophy. Russian annals of ophthalmology. 2003;119(6):18–21. EDN: TUDJXZ</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Neroev VV, Sarygina OI, Zueva MV, Tsapenko IV, Egorova EN. Impact of ozone therapy on the electrophysiological parameters of the retina in patients operated on for its rhegmatogenous detachment. Russian annals of ophthalmology. 2007;123(5):33–36. EDN: UIZOSJ</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Borrelli E, Diadori A, Zalaffi A, et al. Effects of major ozonatedautohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study. Int J Ophthalmol. 2012;5(6):708–713. doi: 10.3980/j.issn.2222-3959.2012.06.11</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Sаbirova D, Tulikova G, Palvanov Kh, Azimov K. Evaluation of the Effectiveness of Ozone Therapy in Age-Related Macular Degeneration. Bulletin of the Doctor. 2013;1(3):179–180. (In Russ.)</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Kulikova MP, Aksenova SV, Neverova EA. Clinical Effectiveness of Ozone Therapy in the Complex Treatment of Patients with Uveitis. Mordovia university bulletin. 2006;16(2):67–72. EDN: TEHXUB</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Chernysheva AD. Application of ozone and plasmapheresis in the complex treatment of uveitis. Bulletin of siberian medicine. 2009;8(3):117–120. doi: 10.20538/1682-0363-2009-3-117-120 EDN: KVMYTD</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Guliyeva MG. Comparative clinical study the effectiveness of plasmapheresis with ozone therapy in the prevention of ocular herpes recurrence. Oftal`mologiya. 2019;16(1):76–80. doi: 10.18008/1816-5095-2019-1-76-80 EDN: VXHVPZ</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Chakieva AR, Gaidamak VV, Bazarbaeva ChS. Evalution of the state of the lipoperoxidation and enzymal antioxidant protection in treatment of high-grade complicated myopia. Vestnik of KSMA named after I.K. Akhunbaev. 2022;(2):163–166. doi: 10.54890/1694-640520222162. EDN: FZJOFC</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Lapkina II. Features of the dynamics of interrelations of the indicators of the state of the retina in the process of ozone therapy in the complicated form of myopia. Bulletin of Problems in Biology and Medicine. 2013;2(3):176–180. EDN: RSBQEX</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Kurzhupova NS, Baranov VI. Dynamics of Visual Functions in the Application of Ozone Therapy in the Complex Treatment of Patients with Primary Open-Angle Glaucoma. Scientific Bulletin of Belgorod State University. Series: Medicine. Pharmacy. 2014;(11–1):40–44. (In Russ.) EDN: QLGRDX</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Nechepurenko OA, Kolesnikova LN, Falhout OS, Fedorov AA, Medvedev IB. Possibilities of ozonoterapy in hemophthalm treatment. Oftal`mologiya. 2010;7(3):26–28. EDN: NCHSJZ</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Nechepurenko OA, Kolesnikova LN, Falchut OS, Medvedev IB. New aspects of therapy of hemophthalm caused by hypertension and diabetes mellitus. Oftal`mologiya. 2011;8(2):53–55. EDN: ONDNOH</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Kulikov AG, Kiseleva ОM. Physical factors in the treatment of diabetic retinopathy. Russian journal of the physical therapy, balneotherapy and rehabilitation. 2003;(4):25–28. EDN: ONMHPD</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Kulikov A, Kiselyeva O. Diabetic retinopathy: physiotherapy resources. Medicinskij vestnik MVD. 2019;(1):55–59. EDN: VSGRDM</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Yurova OV, Turova EA, Morozova NE, Nazarova GA, Rogan OA. Treatment and secondary prophylaxis integrated approach at non-proliferative diabetic retinopathy. Oftal`mologiya. 2011;8(3):9–12. EDN: OMSCIP</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Borzenok SA, Kulikov AG, Kiseleva OM. Results of the use of ozone in the complex treatment of diabetic retinopathy. Oftal`moxirurgiya. 2003;(4):29–32. EDN: PXQZHD</mixed-citation></ref></ref-list></back></article>
